Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P00441: Variant p.Leu9Val

Superoxide dismutase [Cu-Zn]
Gene: SOD1
Feedback?
Variant information Variant position: help 9 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Leucine (L) to Valine (V) at position 9 (L9V, p.Leu9Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Similar physico-chemical property. Both residues are medium size and hydrophobic. The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 1 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In ALS1. Any additional useful information about the variant.
Other resources: help Links to websites of interest for the variant.


Sequence information Variant position: help 9 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 154 The length of the canonical sequence.
Location on the sequence: help MATKAVCV L KGDGPVQGIINFEQKESNGP The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Initiator methionine 1 – 1 Removed
Chain 2 – 154 Superoxide dismutase [Cu-Zn]
Modified residue 2 – 2 N-acetylalanine
Modified residue 4 – 4 N6-succinyllysine
Modified residue 10 – 10 N6-succinyllysine
Lipidation 7 – 7 S-palmitoyl cysteine
Mutagenesis 7 – 7 C -> S. Enhances formation of fibrillar aggregates in the absence of bound zinc; when associated with S-58; S-112 and S-147.
Mutagenesis 7 – 7 C -> S. No palmitoylation, reduced nuclear targeting.
Beta strand 3 – 10



Literature citations
Three novel mutations and two variants in the gene for Cu/Zn superoxide dismutase in familial amyotrophic lateral sclerosis.
Hosler B.A.; Nicholson G.A.; Sapp P.C.; Chin W.; Orrell R.W.; de Belleroche J.S.; Esteban J.; Hayward L.J.; Mckenna-Yasek D.; Yeung L.; Cherryson A.K.; Dench J.E.; Wilton S.D.; Laing N.G.; Horvitz R.H.; Brown R.H. Jr.;
Neuromuscul. Disord. 6:361-366(1996)
Cited for: VARIANTS ALS1 VAL-94; VAL-125 AND GLU-134 DEL; A novel mutation Asp90Val in the SOD1 gene associated with Japanese familial ALS.
Morita M.; Abe K.; Takahashi M.; Onodera Y.; Okumura H.; Niino M.; Tashiro K.; Nakano I.; Itoyama Y.;
Cited for: VARIANT ALS1 VAL-91; Sixteen novel mutations in the Cu/Zn superoxide dismutase gene in amyotrophic lateral sclerosis: a decade of discoveries, defects and disputes.
Andersen P.M.; Sims K.B.; Xin W.W.; Kiely R.; O'Neill G.; Ravits J.; Pioro E.; Harati Y.; Brower R.D.; Levine J.S.; Heinicke H.U.; Seltzer W.; Boss M.; Brown R.H. Jr.;
Amyotroph. Lateral Scler. 4:62-73(2003)
Cited for: VARIANTS ALS1 VAL-9; CYS-21; LEU-23; ARG-49; ARG-55; ALA-88; THR-90; MET-98; LEU-106; ALA-115; LEU-119; GLY-125 AND ARG-148; Oligogenic basis of sporadic ALS: The example of SOD1 p.Ala90Val mutation.
Kuuluvainen L.; Kaivola K.; Moenkaere S.; Laaksovirta H.; Jokela M.; Udd B.; Valori M.; Pasanen P.; Paetau A.; Traynor B.J.; Stone D.J.; Schleutker J.; Poeyhoenen M.; Tienari P.J.; Myllykangas L.;
Neurol. Genet. 5:e335-e335(2019)
Cited for: VARIANT ALS1 VAL-90;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.